Gyroscope Therapeutics
Clinical-stage gene therapy company focused on diseases of the eye.
Gyroscope Therapeutics has raised €35M across 1 funding round from 1 investor, most recently a round in Nov 2021. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKgyroscopetx.com ↗
Total raised
€35M
€34,551,265
Funding rounds
1
Investors
1
distinct backers
Active since
2021-11
latest 2021-11
Funding by year
EUR raised per yearGyroscope Therapeutics — funding by year — interactive chart.
Data table
| Gyroscope Therapeutics — funding by year | |
|---|---|
| 2021 | €35M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-09 | Other | €35M | Sanofi Ventures | View deal → |
Investors
1Related news
- Gyroscope Therapeutics Receives Up To $60M Equity Investment From Sanofifinsmes.com · 2021-11
Similar companies
same sector or countryGlobal coverage: FundingData